TMO
Thermo Fisher Scientific Inc.
- Gross profit, 2025
- $18.2B
- YoY, 2025
- +3.0%
- 5-year CAGR
- +2.6%
- 10-year CAGR
- +8.9%
Gross profit
Gross profit by fiscal year
| Period | Gross profit | YoY |
|---|---|---|
| 2025 | $18.2B | +3.0% |
| 2024 | $17.7B | +3.5% |
| 2023 | $17.1B | −9.9% |
| 2022 | $19.0B | −3.4% |
| 2021 | $19.6B | +22.7% |
| 2020 | $16.0B | — |
| 2017 | $9.4B | +12.9% |
| 2016 | $8.4B | +7.9% |
| 2015 | $7.8B | +3.5% |
| 2014 | $7.5B | +35.5% |
| 2013 | $5.5B | +4.4% |
| 2012 | $5.3B | +10.5% |
| 2011 | $4.8B | +12.5% |
| 2010 | $4.3B | +9.3% |
| 2009 | $3.9B | −7.3% |
| 2008 | $4.2B | +10.6% |
| 2007 | $3.8B | — |